| Year |
Citation |
Score |
| 2024 |
Xu J, Bock CH, Janisse J, Woo J, Cher ML, Ginsburg K, Yacoub R, Goodman M. Determinants of active surveillance uptake in a diverse population-based cohort of men with low-risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS). Cancer. PMID 38247317 DOI: 10.1002/cncr.35190 |
0.548 |
|
| 2022 |
Xu J, Goodman M, Janisse J, Cher ML, Bock CH. Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol. Bmj Open. 12: e056675. PMID 35190441 DOI: 10.1136/bmjopen-2021-056675 |
0.513 |
|
| 2021 |
Xu J, Bock C, Janisse J, Schwartz KL, Triest J, Cher M, Goodman M. Urologists' Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients. Urology. PMID 33482128 DOI: 10.1016/j.urology.2020.12.037 |
0.485 |
|
| 2020 |
Du Z, Weinhold N, Song GC, Rand KA, Van Den Berg DJ, Hwang AE, Sheng X, Hom V, Ailawadhi S, Nooka AK, Singhal S, Pawlish K, Peters ES, Bock C, Mohrbacher A, et al. A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry. Blood Advances. 4: 181-190. PMID 31935283 DOI: 10.1182/Bloodadvances.2019000491 |
0.347 |
|
| 2020 |
Levin AM, Dyson G, Boerner JL, Ruterbusch JJ, Bock CH. Abstract C039: Investigation of a prostate cancer genetic susceptibility candidate region on chromosome 5 in African Americans Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-C039 |
0.539 |
|
| 2019 |
Heath EI, Nanus DM, Slovin S, Strand C, Higano C, Simons VH, Johnson C, Kyriakopoulos CE, Reichert ZR, Lory S, George DJ, Mucci LA, Marcus JD, Trendel JA, Bock CH. Prostate Cancer National Summit's Call to Action. Clinical Genitourinary Cancer. PMID 31085057 DOI: 10.1016/J.Clgc.2019.04.002 |
0.584 |
|
| 2019 |
Kachuri L, Du Z, Weinhold N, Song G, Rand KA, Van Den Berg D, Hwang A, Sheng X, Hom V, Ailawadhi S, Nooka AK, Singhal S, Peters ES, Bock C, Mohrbacher A, et al. Comprehensive Investigation of White Blood Cell and Gene Expression Profiles As Risk Factors for Multiple Myeloma in African Americans Blood. 134: 4379-4379. DOI: 10.1182/Blood-2019-129298 |
0.356 |
|
| 2018 |
Dyson G, Farran B, Bolton S, Craig DB, Dombkowski A, Beebe-Dimmer JL, Powell IJ, Podgorski I, Heilbrun LK, Bock CH. The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancer. American Journal of Cancer Research. 8: 2088-2095. PMID 30416858 |
0.443 |
|
| 2018 |
Cook MB, Barnett MJ, Bock CH, Cross AJ, Goodman PJ, Goodman GE, Haiman CA, Khaw KT, McCullough ML, Newton CC, Boutron-Ruault MC, Lund E, Rutegård M, Thornquist MD, Spriggs M, et al. Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium. Gut. PMID 30121626 DOI: 10.1136/Gutjnl-2018-316678 |
0.398 |
|
| 2018 |
Bock CH, Ruterbusch JJ, Holowatyj AN, Steck SE, Van Dyke AL, Ho WJ, Cote ML, Hofmann JN, Davis F, Graubard BI, Schwartz KL, Purdue MP. Renal cell carcinoma risk associated with lower intake of micronutrients. Cancer Medicine. PMID 29968964 DOI: 10.1002/Cam4.1639 |
0.357 |
|
| 2018 |
Farran B, Dyson G, Craig D, Dombkowski A, Beebe-Dimmer JL, Powell IJ, Podgorski I, Heilbrun L, Bolton S, Bock CH. A Study of Circulating microRNAs Identifies a New Potential Biomarker Panel to Distinguish Aggressive Prostate Cancer. Carcinogenesis. PMID 29471417 DOI: 10.1093/Carcin/Bgy025 |
0.431 |
|
| 2018 |
Du Z, Song C, Rand K, Weinhold N, Berg DVD, Hwang A, Sheng X, Hom V, Ailawadhi S, Nooka AK, Singhal S, Pawlish K, Peters ES, Bock C, Mohrbacher A, et al. Abstract 223: A meta-analysis of genome-wide association studies of multiple myeloma among African Americans Cancer Research. 78: 223-223. DOI: 10.1158/1538-7445.Am2018-223 |
0.515 |
|
| 2017 |
Beebe-Dimmer JL, Yee C, Paskett E, Schwartz AG, Lane D, Palmer NRA, Bock CH, Nassir R, Simon MS. Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women's health initiative. Bmc Cancer. 17: 848. PMID 29237415 DOI: 10.1186/S12885-017-3873-5 |
0.575 |
|
| 2017 |
Bock CH, Jay AM, Dyson G, Beebe-Dimmer JL, Cote ML, Hou L, Howard BV, Desai P, Purrington K, Prentice R, Simon MS. The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study. Breast Cancer Research and Treatment. PMID 29063981 DOI: 10.1007/S10549-017-4521-0 |
0.355 |
|
| 2017 |
Kato I, Lane D, Womack CR, Bock CH, Hou L, Lin JH, Wu C, Beebe Dimmer J, Simon MS. Interaction between Nonsteroidal Anti-inflammatory Drugs and Low-fat Dietary Intervention on Colorectal Cancer Incidence; the Women's Health Initiative (WHI) Dietary Modification Trial. Journal of the American College of Nutrition. 1-8. PMID 28682183 DOI: 10.1080/07315724.2017.1321505 |
0.375 |
|
| 2017 |
Wizner C, Ruterbusch J, Kubinec N, Dyson G, Levin A, Boerner J, Bock C. Abstract B33: Determination of protein expression of candidate prostate cancer genes from a novel region on chromosome 7 identified in African American men Cancer Epidemiology, Biomarkers & Prevention. 26. DOI: 10.1158/1538-7755.Disp16-B33 |
0.608 |
|
| 2016 |
Gragert L, Hwang A, Bernal-Mizrachi L, Ailawadhi S, Singhal S, Vandenberg DJ, Sheng X, Stram A, Conti DV, Rand KA, Song C, Graff JJ, Janakiraman N, Mehta J, Stram DO, ... Bock C, et al. HLA Haplotypes Are Associated with Multiple Myeloma Risk in the African American Multiple Myeloma Study (AAMMS) Blood. 128: 3250-3250. DOI: 10.1182/Blood.V128.22.3250.3250 |
0.361 |
|
| 2015 |
Kato I, Young A, Liu J, Abrams J, Bock C, Simon M. Electric Blanket Use and Risk of Thyroid Cancer in the Women's Health Initiative Observational Cohort. Women & Health. 1-13. PMID 25996298 DOI: 10.1080/03630242.2015.1050545 |
0.41 |
|
| 2015 |
Beebe-Dimmer JL, Yee C, Cote ML, Petrucelli N, Palmer N, Bock C, Lane D, Agalliu I, Stefanick ML, Simon MS. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study. Cancer. 121: 1265-72. PMID 25754547 DOI: 10.1002/Cncr.29075 |
0.516 |
|
| 2015 |
Beebe-Dimmer J, Heilbrun L, Bock C, Smith D, Podgorski I, Bolton S, Powell I, Beebe-Dimmer J. MP14-15 METABOLIC SYNDROME AND AGGRESSIVE PROSTATE CANCER AND BIOCHEMICAL RECURRENCE AFTER DEFINITIVE TREATMENT Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.877 |
0.517 |
|
| 2014 |
Powell IJ, Vigneau FD, Bock CH, Ruterbusch J, Heilbrun LK. Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1505-11. PMID 24802741 DOI: 10.1158/1055-9965.Epi-13-1328 |
0.594 |
|
| 2014 |
Neslund-Dudas C, Levin AM, Beebe-Dimmer JL, Bock CH, Nock NL, Rundle A, Jankowski M, Krajenta R, Dou QP, Mitra B, Tang D, Rebbeck TR, Rybicki BA. Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men. Cancer Causes & Control : Ccc. 25: 869-79. PMID 24801046 DOI: 10.1007/S10552-014-0387-1 |
0.569 |
|
| 2014 |
Neslund-Dudas C, Levin AM, Rundle A, Beebe-Dimmer J, Bock CH, Nock NL, Jankowski M, Datta I, Krajenta R, Dou QP, Mitra B, Tang D, Rybicki BA. Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancer. The Prostate. 74: 637-46. PMID 24500903 DOI: 10.1002/Pros.22781 |
0.566 |
|
| 2014 |
Ho WJ, Simon MS, Yildiz VO, Shikany J, Kato I, Beebe-Dimmer J, Cetnar JP, Bock C. Antioxidant micronutrients and renal cell carcinoma: Results from the Women’s Health Initiative. Journal of Clinical Oncology. 32: 1515-1515. DOI: 10.1200/Jco.2014.32.15_Suppl.1515 |
0.311 |
|
| 2014 |
Rand KA, Song C, Hwang AE, Huff CA, Bernal-Mizrachi L, Tomasson MH, Ailawadhi S, Van Den Berg DJ, Sheng X, Graff JJ, Conti DV, Zimmerman T, Peters E, Singhal S, Bock CH, et al. Genetic Susceptibility Markers of Multiple Myeloma in African-Americans Blood. 124: 2030-2030. DOI: 10.1182/Blood.V124.21.2030.2030 |
0.43 |
|
| 2014 |
Hwang AE, Ailwadhi S, Huff CA, Bernal-Mizrachi L, Haiman CA, Peters E, Singhal S, Pawlish K, Bock C, Zimmerman T, Berg DJVD, Conti DV, Birmann BB, Mehta J, Graff JJ, et al. Abstract 3852: Obesity is associated with clinical characteristics in African American multiple myeloma patients Cancer Research. 74: 3852-3852. DOI: 10.1158/1538-7445.Am2014-3852 |
0.351 |
|
| 2013 |
Desai P, Chlebowski R, Cauley JA, Manson JE, Wu C, Martin LW, Jay A, Bock C, Cote M, Petrucelli N, Rosenberg CA, Peters U, Agalliu I, Budrys N, Abdul-Hussein M, et al. Prospective analysis of association between statin use and breast cancer risk in the women's health initiative. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1868-76. PMID 23975947 DOI: 10.1158/1055-9965.Epi-13-0562 |
0.386 |
|
| 2013 |
Monda KL, Chen GK, Taylor KC, Palmer C, Edwards TL, Lange LA, Ng MC, Adeyemo AA, Allison MA, Bielak LF, Chen G, Graff M, Irvin MR, Rhie SK, Li G, ... ... Bock CH, et al. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nature Genetics. 45: 690-6. PMID 23583978 DOI: 10.1038/Ng.2608 |
0.624 |
|
| 2013 |
Powell IJ, Dyson G, Land S, Ruterbusch J, Bock CH, Lenk S, Herawi M, Everson R, Giroux CN, Schwartz AG, Bollig-Fischer A. Genes associated with prostate cancer are differentially expressed in African American and European American men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 891-7. PMID 23515145 DOI: 10.1158/1055-9965.Epi-12-1238 |
0.539 |
|
| 2013 |
Hwang AE, Ailawadhi S, Bernal-Mizrachi L, Zimmerman TM, Haiman C, Van Den Berg DJ, Pawlish K, Mohrbacher AM, Terebelo H, Birmann BM, Stram DO, Conti DV, Janakiraman N, Henderson BE, Kolonel LN, ... ... Bock CH, et al. Obesity In Young Adulthood Is Associated With Early Onset Multiple Myeloma In African Americans Blood. 122: 1872-1872. DOI: 10.1182/Blood.V122.21.1872.1872 |
0.341 |
|
| 2012 |
Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, ... ... Bock CH, et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nature Genetics. 44: 651-8. PMID 22561519 DOI: 10.1038/Ng.2270 |
0.461 |
|
| 2012 |
Cozen W, Hwang AE, Ailawadhi S, Singhal S, Huff CA, Bernal-Mizrachi L, Chiu BC, Brown EE, Peters E, Pawlish K, Ann M, Bock CH, Haiman C, Stram DO, Rand KA, et al. Explaining the Excess Risk of Multiple Myeloma in African-Americans Blood. 120: 4002-4002. DOI: 10.1182/Blood.V120.21.4002.4002 |
0.343 |
|
| 2012 |
Jay AM, Bock CH, Dyson G, Beebe-Dimmer JL, Hou L, Howard BV, Prentice R, Simon MS. Abstract 07: The effect of genetic variants on the relationship between statins and breast cancer in the Women's Health Initiative Observational Study. Cancer Epidemiology Biomarkers & Prevention. 21: 07-7. DOI: 10.1158/1055-9965.Gwas-07 |
0.428 |
|
| 2012 |
Ruterbusch JJ, Levin AM, Kittles R, Rybicki BA, Bock CH. Abstract A66: Admixture and fine mapping in African Americans identifies a susceptibility locus for prostate cancer on chromosome 7. Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-A66 |
0.579 |
|
| 2012 |
Desai P, Jay A, Wu C, Cauley J, Manson J, Peters U, Agalliu I, Abdul-Hussein M, Bock C, Budrys N, Chlebowski R, Cote M, Lane D, Luo J, Martin L, et al. Abstract PD03-09: Statins and breast cancer risk: A follow-up analysis of the Women's Health Initiative Cohort Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Pd03-09 |
0.398 |
|
| 2012 |
Powell I, Heilbrun L, Smith D, Bolton S, Kieley S, Bock C. 1635 AN UPDATE OF PROGRESSION FREE SURVIVAL (PFS) OF LOCALLY ADVANCED PROSTATE CANCER AMONG AFRICAN AMERICAN AND EUROPEAN AMERICAN MEN WHO HAVE UNDERGONE RADICAL PROSTATECTOMY (RP) Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1452 |
0.536 |
|
| 2011 |
Bock CH, Powell I, Kittles RA, Hsing AW, Carpten J. Racial disparities in prostate cancer incidence, biochemical recurrence, and mortality. Prostate Cancer. 2011: 716178. PMID 22203907 DOI: 10.1155/2011/716178 |
0.604 |
|
| 2011 |
Post JM, Beebe-Dimmer JL, Morgenstern H, Neslund-Dudas C, Bock CH, Nock N, Rundle A, Jankowski M, Rybicki BA. The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy. Prostate Cancer. 2011: 245642. PMID 22096652 DOI: 10.1155/2011/245642 |
0.507 |
|
| 2011 |
Rybicki BA, Neslund-Dudas C, Bock CH, Nock NL, Rundle A, Jankowski M, Levin AM, Beebe-Dimmer J, Savera AT, Takahashi S, Shirai T, Tang D. Red wine consumption is inversely associated with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adduct levels in prostate. Cancer Prevention Research (Philadelphia, Pa.). 4: 1636-44. PMID 21846795 DOI: 10.1158/1940-6207.Capr-11-0100 |
0.496 |
|
| 2011 |
Bonilla C, Hooker S, Mason T, Bock CH, Kittles RA. Prostate cancer susceptibility Loci identified on chromosome 12 in African Americans. Plos One. 6: e16044. PMID 21358824 DOI: 10.1371/Journal.Pone.0016044 |
0.52 |
|
| 2011 |
Schwartz AG, Wenzlaff AS, Bock CH, Ruterbusch JJ, Chen W, Cote ML, Artis AS, Van Dyke AL, Land SJ, Harris CC, Pine SR, Spitz MR, Amos CI, Levin AM, McKeigue PM. Admixture mapping of lung cancer in 1812 African-Americans. Carcinogenesis. 32: 312-7. PMID 21115650 DOI: 10.1093/Carcin/Bgq252 |
0.454 |
|
| 2011 |
Rybicki B, Mitrache N, Do K, Jankowski M, Tang D, Rundle A, Bock C, Beebe-Dimmer J, Belinsky S. Methylation of Retinoic Acid Receptor, Beta (RARB) Gene Increases Risk for Prostate Cancer in African-American Men Cancer Epidemiology Biomarkers & Prevention. 20: 718-718. DOI: 10.1158/1055-9965.Epi-11-0091 |
0.629 |
|
| 2011 |
Powell I, Vigneau F, Ruterbusch J, Heilbrun L, Bock C. 1201 EARLIER AGE FOR PROSTATE CANCER SCREENING OF AFRICAN AMERICAN MEN IS NEEDED TO ELIMINATE RACIAL MORTALITY DISPARITY Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.836 |
0.538 |
|
| 2010 |
Powell IJ, Bock CH, Ruterbusch JJ, Sakr W. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. The Journal of Urology. 183: 1792-6. PMID 20299055 DOI: 10.1016/J.Juro.2010.01.015 |
0.573 |
|
| 2010 |
Bock CH, Schwartz AG, Levin AM, Ruterbusch JJ, Kittles RA, Rybicki BA. Abstract 2847: TagSNPs in the podocalyxin (PODXL) gene are associated with prostate cancer risk Cancer Research. 70: 2847-2847. DOI: 10.1158/1538-7445.Am10-2847 |
0.621 |
|
| 2009 |
Bock CH, Schwartz AG, Ruterbusch JJ, Levin AM, Neslund-Dudas C, Land SJ, Wenzlaff AS, Reich D, McKeigue P, Chen W, Heath EI, Powell IJ, Kittles RA, Rybicki BA. Results from a prostate cancer admixture mapping study in African-American men. Human Genetics. 126: 637-42. PMID 19568772 DOI: 10.1007/S00439-009-0712-Z |
0.578 |
|
| 2009 |
Nock NL, Bock C, Neslund-Dudas C, Beebe-Dimmer J, Rundle A, Tang D, Jankowski M, Rybicki BA. Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity. Cancer Causes & Control : Ccc. 20: 1915-26. PMID 19568698 DOI: 10.1007/S10552-009-9385-0 |
0.61 |
|
| 2009 |
Beebe-Dimmer JL, Nock NL, Neslund-Dudas C, Rundle A, Bock CH, Tang D, Jankowski M, Rybicki BA. Racial differences in risk of prostate cancer associated with metabolic syndrome. Urology. 74: 185-90. PMID 19428088 DOI: 10.1016/J.Urology.2009.03.013 |
0.491 |
|
| 2009 |
Bonilla C, Bock C, Ahaghotu C, Ruterbusch J, Kittles R, Powell IJ. CYP3A GENE CLUSTER, POPULATION STRATIFICATION, AND PROSTATE CANCER RISK Journal of Urology. 181: 818-818. DOI: 10.1016/S0022-5347(09)62280-1 |
0.525 |
|
| 2009 |
Powell IJ, Ruterbusch J, Schwartz A, Bock C. EVIDENCE IN SUPPORT OF EARLIER PSA TESTING IN AFRICAN AMERICAN MEN AGE 35 The Journal of Urology. 181: 642. DOI: 10.1016/S0022-5347(09)61804-8 |
0.378 |
|
| 2009 |
Powell IJ, Bock C, Ruterbusch J, Sakr W. CLINICAL EVIDENCE SUPPORTS A FASTER GROWTH RATE FOR PROSTATE CANCER AMONG AFRICAN AMERICANS COMPARED TO EUROPEAN AMERICAN MEN Journal of Urology. 181: 62-62. DOI: 10.1016/S0022-5347(09)60184-1 |
0.545 |
|
| 2008 |
Rybicki BA, Neslund-Dudas C, Bock CH, Rundle A, Savera AT, Yang JJ, Nock NL, Tang D. Polycyclic aromatic hydrocarbon--DNA adducts in prostate and biochemical recurrence after prostatectomy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 750-7. PMID 18245535 DOI: 10.1158/1078-0432.Ccr-07-0986 |
0.402 |
|
| 2008 |
Terlecki R, Liss Z, Bock C, Pontes J. OUTCOME OF RADICAL PROSTATECTOMY IN HIGH RISK PROSTATE CANCER RADICAL PROSTATECTOMY AS MONOTHERAPHY OR AS PART OF MULTIMODAL MANAGEMENT OF HIGH GRADE PROSTATE CANCER WITH 10 YEAR MINIMUM FOLLOW UP European Urology Supplements. 7: 100. DOI: 10.1016/S1569-9056(08)60119-0 |
0.496 |
|
| 2008 |
Terlecki RP, Liss ZJ, Bock CH, Heath MA, Pontes JE. RADICAL PROSTATECTOMY AS MONOTHERAPY OR AS PART OF MULTIMODAL MANAGEMENT OF HIGH GRADE PROSTATE CANCER WITH 10 YEAR MINIMUM FOLLOW UP Journal of Urology. 179: 652-652. DOI: 10.1016/S0022-5347(08)61904-7 |
0.544 |
|
| 2007 |
Neslund-Dudas C, Bock CH, Monaghan K, Nock NL, Yang JJ, Rundle A, Tang D, Rybicki BA. SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness. The Prostate. 67: 1654-63. PMID 17823934 DOI: 10.1002/Pros.20625 |
0.539 |
|
| 2007 |
Nock NL, Tang D, Rundle A, Neslund-Dudas C, Savera AT, Bock CH, Monaghan KG, Koprowski A, Mitrache N, Yang JJ, Rybicki BA. Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1236-45. PMID 17548691 DOI: 10.1158/1055-9965.Epi-06-0736 |
0.43 |
|
| 2007 |
Tang D, Liu JJ, Bock CH, Neslund-Dudas C, Rundle A, Savera AT, Yang JJ, Nock NL, Rybicki BA. Racial differences in clinical and pathological associations with PhIP-DNA adducts in prostate. International Journal of Cancer. Journal International Du Cancer. 121: 1319-24. PMID 17487839 DOI: 10.1002/Ijc.22806 |
0.465 |
|
| 2007 |
Tang D, Liu JJ, Rundle A, Neslund-Dudas C, Savera AT, Bock CH, Nock NL, Yang JJ, Rybicki BA. Grilled meat consumption and PhIP-DNA adducts in prostate carcinogenesis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 803-8. PMID 17416774 DOI: 10.1158/1055-9965.Epi-06-0973 |
0.544 |
|
| 2007 |
Schwartz AG, Prysak GM, Bock CH, Cote ML. The molecular epidemiology of lung cancer. Carcinogenesis. 28: 507-18. PMID 17183062 DOI: 10.1093/Carcin/Bgl253 |
0.369 |
|
| 2007 |
Cote ML, Wenzlaff AS, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG. Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Lung Cancer (Amsterdam, Netherlands). 55: 255-62. PMID 17174438 DOI: 10.1016/J.Lungcan.2006.11.002 |
0.432 |
|
| 2006 |
Beebe-Dimmer JL, Drake EA, Dunn RL, Bock CH, Montie JE, Cooney KA. Association between family history of prostate and breast cancer among African-American men with prostate cancer. Urology. 68: 1072-6. PMID 17095075 DOI: 10.1016/J.Urology.2006.06.028 |
0.605 |
|
| 2006 |
Rybicki BA, Neslund-Dudas C, Nock NL, Schultz LR, Eklund L, Rosbolt J, Bock CH, Monaghan KG. Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism. Cancer Detection and Prevention. 30: 412-22. PMID 17067754 DOI: 10.1016/J.Cdp.2006.09.004 |
0.571 |
|
| 2005 |
Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis. 26: 2207-12. PMID 16051642 DOI: 10.1093/Carcin/Bgi191 |
0.409 |
|
| 2005 |
Patel DA, Bock CH, Schwartz K, Wenzlaff AS, Demers RY, Severson RK. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan. Cancer Causes & Control : Ccc. 16: 263-73. PMID 15947878 DOI: 10.1007/S10552-004-3486-6 |
0.6 |
|
| 2005 |
Bock CH, Peyser PA, Montie JE, Cooney KA. Decreasing age at prostate cancer diagnosis over successive generations in prostate cancer families. The Prostate. 64: 60-6. PMID 15651090 DOI: 10.1002/Pros.20220 |
0.72 |
|
| 2005 |
Wenzlaff AS, Cote ML, Bock CH, Land SJ, Schwartz AG. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: A population-based study Carcinogenesis. 26: 395-401. PMID 15528218 DOI: 10.1093/Carcin/Bgh326 |
0.404 |
|
| 2005 |
Bock CH, Wenzlaff AS, Cote ML, Land SJ, Schwartz AG. NQ01 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: Results from a population-based study Carcinogenesis. 26: 381-386. PMID 15498787 DOI: 10.1093/Carcin/Bgh314 |
0.402 |
|
| 2004 |
Giri VN, Cassidy AE, Beebe-Dimmer J, Ellis L, Smith DC, Bock CH, Cooney KA. Association between Agent Orange and prostate cancer: a pilot case-control study. Urology. 63: 757-60; discussion 7. PMID 15072895 DOI: 10.1016/J.Urology.2003.11.044 |
0.756 |
|
| 2004 |
Giri VN, Cassidy AE, Beebe-Dimmer J, Ellis LR, Smith DC, Bock CH, Cooney KA. Erratum: Association between agent orange and prostate cancer: A pilot case-control study (Urology (April 2004) 63 (757-761)) Urology. 63. DOI: 10.1016/J.Urology.2004.05.001 |
0.747 |
|
| 2003 |
Bock CH, Peyser PA, Gruber SB, Bonnell SE, Tedesco KL, Cooney KA. Prostate cancer early detection practices among men with a family history of disease. Urology. 62: 470-5. PMID 12946749 DOI: 10.1016/S0090-4295(03)00382-0 |
0.72 |
|
| 2001 |
Bock CH, Cunningham JM, McDonnell SK, Schaid DJ, Peterson BJ, Pavlic RJ, Schroeder JJ, Klein J, French AJ, Marks A, Thibodeau SN, Lange EM, Cooney KA. Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer. American Journal of Human Genetics. 68: 795-801. PMID 11179028 DOI: 10.1086/318797 |
0.599 |
|
| 1999 |
Lange EM, Chen H, Brierley K, Perrone EE, Bock CH, Gillanders E, Ray ME, Cooney KA. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX Clinical Cancer Research. 5: 4013-4020. PMID 10632333 |
0.497 |
|
| Show low-probability matches. |